Top of page
Global Site Navigation

School of Medical Sciences

Local Section Navigation
You are here:
ECU is currently converting this web content to a more mobile friendly format. If you find the content below is not formatting correctly during this transition please view on desktop browser.
Main Content

ECU Melanoma Research Group

The ECU Melanoma Research Group’s primary focus is to develop a simple blood test to detect circulating metastatic melanoma cells. Early identification of disease and disease spread will allow medical specialists to recommend an appropriate course of treatment at an early stage, thus improving the likelihood of treatment success. Local and international clinicians working closely with ECU researchers are enthusiastic about the research stating that “the blood test developed by ECU researchers will revolutionise the way melanoma patients are treated”.

The research

To develop the blood test, it is required to identify a group of genetic markers that are expressed in the blood of patients with melanoma, and not in the blood of healthy volunteers. Due to differences in gene expression in many melanoma cells and between patients, several markers are necessary for the accurate detection of melanoma cells in the blood.

Several state-of-the-art biochemical and molecular tools are being used to hunt for new genes which can help to gain a better understanding of the mechanisms causing cancer spread. Further research is aimed at defining the most accurate set of markers for a diagnostic and prognostic blood test.

Skip to top of page